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Abstract Metastatic disease in the intradural compartment
of the spine is a rare manifestation of cancer. We report the
case of an 82-year-old patient with an intradural, extra-
medullary metastasis of renal cell carcinoma in the cervical
spine. A literature search for intradural spinal metastases of
renal cell carcinoma yielded a total of 26 further cases. 18
patients had sporadic renal cell carcinoma, and 9 patients
had von Hippel-Lindau disease (VHL) in which the
metastases of the renal cell carcinoma were embedded
within spinal haemangioblastomas. Patients presented with
paresis, back pain, altered sensation or, less frequently,
bladder dysfunction. Intradural spinal metastases were
diagnosed at an earlier age in VHL patients than in sporadic
cases (mean 43±5 years vs. 60±14.5 years). The metastasis
was surgically removed in 81% of patients. Pain improved
in all patients, paresis in 90%, hypaesthesia in 38% and
bladder dysfunction in 50%. Death occured as a result of
systemic cancer progression. 93% of patients in the
sporadic renal cell cancer group died within 1.5 years,
whereas two thirds of the VHL patients were alive after
2 years.
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Introduction
Metastatic disease in the intradural compartment of the
spine is a rare manifestation of cancer with an incidence of
less than 1% in patients dying from systemic malignancies
[9]. The most commonly associated primary tumours are
cancers of the lung, breast, kidney and skin [38, 44]. Renal
cell carcinoma is usually diagnosed at a disseminated stage
[35]. Advanced disease predominantly presents as metasta-
ses to the lung (50%), bones (49%), lymph nodes (6–32%),
liver (8%) and occasionally brain (3–10%) [32]. We present
an 82 year old patient with an intradural metastasis of renal
cell carcinoma (RCC) in the cervical spine and discuss it in
the context of a further 26 previously published examples
of this condition.
Literature review
The Medline database (PubMed, http://www.ncbi.nlm.nih.
gov/PubMed/) was searched for the keywords intradural
renal cell carcinoma and renal spinal metastasis. After
screening of titles and abstracts, all suitable reports and
important cross-references were obtained as full copies.
Where appropriate, their authors were contacted by mail for
follow-up information, such as progression of local or
systemic disease and survival since publication.
Clinical details
An 82 year old man presented with progressive, moderately
severe left hemiparesis and neck pain aggravated by
coughing. A year earlier, he had sustained an infarction in
the territory of the right middle cerebral artery, from which
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he had completely recovered. Six years earlier, he had
undergone a nephrectomy for clear-cell renal carcinoma. He
had also undergone orchidectomy for prostatic carcinoma.
Neurological examination revealed a left-sided spastic
hemiparesis of grade III–IV on the Medical Research
Council Scale [18] and was otherwise unremarkable, as
was the general physical examination.
Magnetic resonance imaging (MRI) of the entire spine
revealed a solitary, well-circumscribed intradural tumour at
C6/7, compressing and displacing the spinal cord to the
right. The lesion was iso-intense on T1- and hypo-intense
on T2-weighted images, with slight homogeneous contrast
enhancement (Fig. 1). MRI of the brain disclosed a small
0.8×0.6 cm extra-axial contrast enhancing lesion at the left
foramen of Luschka (Fig. 2). In consideration of the
patient’s advanced age and the small size of the cerebral
lesion, Gamma Knife therapy was planned. Surgery was
recommended for the symptomatic, space-occupying, well-
defined tumour in the spine. A C6 laminectomy was
performed. When the dura mater was opened, the tumour
was found to be attached to the left C6 root. Macroscopi-
cally, it displayed a nerve sheath tumour-like aspect with a
rubbery consistency and a well demarcated cleavage plane.
Histopathology of the completely removed lesion revealed
partly haemorrhagic, highly vascularised tissue consisting
of clear cells arranged in small lobules (Fig. 3). The tumour
cells had pronounced cytoplasmic accumulations of PAS-
positive granules, reflecting glycogen deposition. Immuno-
histochemical staining revealed strong reactivity with the
pan-cytokeratin marker CK22 as well as with a renal cell
carcinoma marker (NCL-RCC, clone 66.4.C2). Post-
operatively, the left hemiparesis improved progressively.
Adjuvant local irradiation was administered. One year after
surgery, the patient is doing well and is able to walk
unaided.
Results
A Medline literature search yielded 19 articles dating from
1990 to 2007 concerning 32 examples of intradural spinal
cord metastases (ISCM) of renal cell carcinoma [1, 2, 4, 5,
11, 13, 15, 19, 20, 22–24, 28, 29, 33, 38, 39, 41, 42]. Six of
these dated from the pre-CT and pre-MRI era and were
therefore discarded from the analysis [15]. A total of 18
patients, including our patient, had sporadic RCC (Table 1)
[2, 4, 5, 12, 14, 19, 23, 24, 28, 29, 39, 41], while 9 patients
had von Hippel-Lindau disease (VHL) (Table 2) [1, 4, 13,
19, 20]. In the latter group of patients, RCC was found
within haemangioblastomas of the spinal cord as a tumour-
to-tumour metastasis. Eleven of the patients with sporadic
RCC were male, and 7 were female. In the VHL group,
female patients (n=6) predominated over male patients
(n=3). Nine ISCM were located in the cervical, 8 in the
thoracic, 9 in the lumbar, and one in the sacral spine. All
intradural metastases occurring between C1 and L1-2 were
intramedullary except for our patient in whom the lesion
mimicked an extradural extramedullary nerve sheath tu-
mour. All intradural metastases below the conus medullaris
were extramedullary, as expected.
Patients presented with limb paresis (n=20, 74%), back
pain (n=15, 56%), hypaesthesia or paraesthesia (n=13,
48%) and bladder dysfunction (n=6, 22%). In 4 patients
Fig. 1 T2-weighted sagittal MRI of the cervical spine revealed a
sharply circumscribed, intradural/extramedullary, hypointense tumour
at C6/7 with dorsal displacement of the spinal cord
Fig. 2 Contrast-enhanced, T1-weighted axial MRI of the brain
showed a small, homogeneously enhancing lesion at the left foramen
of Luschka
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(15%), cervical or upper thoracic ISCM caused at least a
partial Brown-Séquard syndrome [11, 13, 39]. The lesion
was surgically resected in 22 (81%) patients. In four (15%)
adjuvant post-operative radiotherapy was administered [11,
15, 28]. Five (19%) patients received external beam
radiotherapy without surgery [13, 33]. All patients experi-
enced pain relief. Muscle strength improved in 18 of 20
patients (90%), hypaesthesia in 5 of 13 (38%) and urinary
disturbance in 3 of 6 (50%). Histopathology confirmed
metastatic renal cell cancer in all patients; the metastases
were admixed with a haemangioblastoma lesion in the
patients with VHL [1, 4, 13, 19, 20, 34].
Sporadic cases
The mean age at diagnosis of RCC and ISCM was 57±
13 years (range, 36 to 78) and 60±14.5 years (range, 36 to
84), respectively. In the majority of sporadic cases (13 of
18, 72%), ISCM occurred after renal cell carcinoma had
already been diagnosed, at a mean latency of 4.3 years
(range 2 months to 15 years). In the remaining 5 patients
(28%), ISCM was the first manifestation of disease [11, 13,
16, 19, 39]. When ISCM was diagnosed, 6 patients (33%)
had no other metastases [2, 5, 13, 23, 29, 39]. Among the
12 patients (66%) with systemic disease, 9 (50%) had
involvement of the lungs [11, 13, 16, 24, 33, 41] and 4
(22%) of the brain [13, 15], while a further 4 patients
developed brain metastases later on [13, 33, 41]. Metastasis
to the brain was a frequent event in RCC (44% of all
patients). Brain metastases were treated with external beam
radiotherapy (n=5) [13, 15, 33], with corticosteroids (n=2)
[13] and with surgery (n=1) [33]. In 5 patients, lung
metastases appeared before ISCM was diagnosed [13, 24,
33, 41]. Interestingly, an aggressive strategy consisting of
nephrectomy, resection of lung metastases and chemother-
apy was associated with late development of ISCM, namely
6, 7 and 15 years after the diagnosis of RCC [13, 24, 41]. In
the patients that had been treated with nephrectomy and
chemo- or immunotherapy alone, ISCM was diagnosed
within a few months [13, 33].
In general, the prognosis was poor. Survival times were
available for 14 patients. Seven (50%) died within 6 months
a b 
c d
Fig. 3 On conventional H&E stains, the clear-cell aspect of the partly
haemorrhagic tumour could easily be appreciated (a). The tumour cell
cytoplasm featured conspicuous PAS-positive granula, corresponding
to glycogen deposits (b). Upon immunohistochemical examination,
tumour cells were found to express cytokeratin (c) as well as a renal
cell carcinoma-specific antigen d). See text for details. Scale bar 50
µm, all images same magnification
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[5, 11, 13, 23] and 13 (93%) within 1.5 years [5, 11, 13, 15,
16, 23, 28, 39]. Only 1 patient survived for 3 years [41].
The overall mean survival time for sporadic RCC was
11 months. Death always manifested as a result of systemic
progression of RCC.
VHL patients
In VHL patients, ISCM was diagnosed at a mean age of
43±5 years (range, 36 to 52). All but two of the VHL
patients had already been diagnosed with this syndrome; for
Table 1 Data from patients with intradural spinal cord metastases (ISCM) from sporadic renal cancer
Case report
Author, year
Age at
RCC,
sex
Time to
ISCM
(months)
level Other RCC
metastases
Treatment Signs & symptoms
before / after treatment
Time to death
after ISCM
(months)
pain motor sens. bladder
Alfieri, 2005 67,f 48 L3-L5 - n, r +/− +/− −/− +/− ?
Ateaque, 2000 52,m 132 C2-C3 - n,r,st −/− +/+ +/+ +/+ 1
Donovan, 2006 41,f 0 C4 l,bo r,xbo,xiscm −/− +/- +/+ −/− 2
Fakih, 2001 56,m 0 C4 l,br xbo,xbr,xiscm,st −/ ? +/ ? ?/ ? +/+ 6
Fakih, 2001 57,f 0 C7 l,br xbo,xbr,xiscm,st +/- +/− +/ ? −/− 5
Fakih, 2001 60,m 180 T1–T2 l,br n,ch,st,r,xbr,xiscm −/− +/− ?/ ? −/− 2
Fakih, 2001 46,m 2 T5 l,br xbo,xiscm,inf,st,ret −/− +/− +/ ? +/− 5
Fakih, 2001 68,f 2 T2 - xiscm,st −/− +/− ?/ ? −/− 16
Gaetani, 2004 36,f 4 L3-L4 br,vi,spi n,r, xbr,xiscm +/− +/− +/− −/− 12
Gomez, 2005 69,m 0 L1 l,vi r +/− +/− +/− −/− 16
Kaya, 2003 43,f 12 L1 - n,r +/− +/− −/− +/− 6
Kubota, 2003 61,m 84 L3 l n,r +/− −/− ?/ ? −/− ?
Mak, 2001 52,m 84 L3–L4 spi n,r,xiscm -/- +/− ?/ ? −/− 18
Maxwell, 1999 78,m 72 L2–L3 - n,r +/- −/− −/− −/− ?
Poggi, 2001 37,m 2 T12 l,bo,br n,xbo,xbr,xiscm,inf,il +/ ? +/ ? +/+ −/− ?
Schijns, 2000 70,f 0 C7 - r +/ ? +/− +/− −/− 13
Takada, 2003 55,m 72 L3 l,br r,inf +/− +/+ +/+ +/+ 36
Present case 76,m 72 C6–C7 br n,r,st +/− +/− −/− −/− >12
l lungs, bo bones, br brain, vi visceral, spi vertebra of the spine, n nephrectomy, r resection of the intraspinal metastasis, xbo radiotherapy to
bones, xiscm to the ISCM, xbr to the brain, st steroids, ch chemotherapy, inf interferon, ret cis-retinoic, il interleukin-2, ? not reported, + present, -
not present.
Table 2 Data from VHL patients with intradural spinal cord metastases (ISCM) of renal cancer
Case report Author, year Age at
RCC,
sex
Time to
ISCM
(months)
level Other RCC
metastases
Treatment Signs & symptoms
before / after treatment
Time to death
after ISCM
(months)
pain motor sens. bladder
A-Hamden, 2003 39,m 0 C1-C4 ? n,r −/− +/− +/+ −/− ?
Altinoz, 2005 43,m 24 T6-T7 l,br,adr n,il,xbr,r,sut +/− −/− −/− −/− >96
Fakih, 2001 37,f 24 C2 l n,il,r +/− +/− +/− −/− 23
Hamazaki, 2001 47,f 0 T5-6,T9 - n,r −/− +/ ? +/ ? −/− >24
Jarrel, 2006 36a,f ? sacrum - r +/− −/− −/− −/− >36
Jarrel, 2006 44a,f ? thoracic - r +/− −/− −/− −/− >12
Jarrel, 2006 41a,m ? thoracic l r −/− +/− −/− −/− 3
Jarrel, 2006 50af ? lumbar - r ?/ ? ?/ ? ?/ ? ?/ ? ?
Polydorides, 2007 46,f 72 cervical ? n,r −/− −/− +/ ? −/− ?
a age at diagnosis of intradural spinal cord metastasis (ISCM), l lungs, br brain, adr adrenals, n neprectomy, r resection of the ISCM, xbr
radiotherapy to the brain, il interleukin-2, sut sunitinib, ? not reported, + present, - not present.
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two of them, however, it was the spinal tumour that
brought the underlying VHL to clinical attention [1, 19].
On average, the time from diagnosis of RCC to diagnosis of
an intradural spinal metastasis was only 1 year. Most of the
VHL patients had known CNS haemangioblastomas. Two
of 8 patients (25%) had lung metastases of RCC 2 years
before diagnosis of ISCM, treated with immunotherapy [4,
13]. One of these (13%) developed a brain metastasis
3 years after ISCM, which was irradiated and resected. This
particular patient also received systemic interleukin-2,
chemotherapy and the anti-angiogenic protein kinase
inhibitor sunitinib and was still alive 6 years after removal
of the ISCM [4, 12]. One patient declined resection of the
primary RCC and died 3 months later of intestinal
obstruction [20]. Two thirds of VHL patients were alive
after 2 years.
Discussion
Intradural metastatic disease to the spine is a rare
complication of cancer. It accounts for only 0.8–3.9% of
all symptomatic spinal metastases [9]. The strategic local-
isation within the intradural spinal compartment often leads
to irreversible neurological deficits. Patients with ISCM
commonly suffer from advanced disease [26]. Therefore,
the main goal of therapy is palliation. Most patients
analysed in this systematic review of published reports
underwent surgical removal of the ISCM, which relieved
pain and improved motor function. Sensory and urinary
dysfunction were less likely to recover. Five patients
received radiotherapy instead of surgery because of
advanced disease [13, 33]. In experienced hands, the
microsurgical resection of an intradural spinal tumour is a
safe procedure [8] and is associated with longer survival
than conservative therapy [21], though selection bias is
likely to play a part in the latter finding. The resection of
metastases provides an effective local treatment and thus
plays an important role in the management of radio-
resistant tumours such as RCC [30]. In this historical and
retrospective series, the male to female distribution in
sporadic RCC reflected the same 1.5 :1 predominance of
men over women found in other studies [27]. In the VHL
group, there were twice as many women as men, but the
number of patients was small. The mean age at presentation
of ISCM in sporadic RCC, 60 years, matched Kalayci’s and
Schiff’s findings in 138 and 40 patients, respectively, with
mixed ISCM [21, 38]. Presumably, because of the
hereditary factor, ISCM of RCC manifested much earlier
in patients with VHL than in sporadic cases. In 40–70% of
VHL patients RCC develop at a mean age of 37 years, as
opposed to a peak incidence between 60 and 70 years for
sporadic RCC [27]. Typically, CNS haemangioblastomas in
VHL cases become symptomatic in the third decade, and
RCC is then detected during screening. In this disease,
germ-line mutations of the tumour suppressor gene VHL on
the short arm of chromosome 3 leads to deficient
ubiquitination of hypoxia-inducible factor, which is in-
volved in the molecular pathogenesis of CNS haemangio-
blastomas, phaeochromocytomas, pancreatic cysts as well
as islet cell tumours, papillary cystadenomas of the
epididymis, renal cysts and carcinoma [40]. Consequently,
individuals with VHL have a reduced average life expec-
tancy of less than 50 years [14].
Intradural spinal cord metastasis is a sign of advanced
disease and therefore associated with a poor prognosis,
irrespective of whether it is intra- or extramedullary.
According to the modified Robson staging system for
RCC, patients with distant metastasis have stage IV cancer
[36], with a 5-year survival from 0 to 10 percent [10].
Indeed, 93% of patients with sporadic RCC were dead
15 months after diagnosis of ISCM (mean survival
11 months), whereas two-thirds of the VHL patients were
alive after 2 years. The cause of death was always systemic
progression of cancer. The bulk of tumours causing
symptomatic ISCM in VHL patients were haemangioblas-
tomas that contained nests of renal cell cancer as a minor
component. Thus, RCC was detected and treated at an
earlier stage. Accordingly, the apparently faster diagnosis of
the spinal metastasis after primary renal cell carcinoma and
the apparently longer survival after ISCM of RCC is
probably due, at least in part, to accelerated diagnosis
because of the co-existing haemangioblastoma. In reports
of ISCM from multiple sources and with mixed treatment
strategies, the mean survival was 3 to 7.3 months, and
9.4 months if only surgically treated cases were considered
[21, 38]. At the outset, 41% of patients had concomitant
brain metastases [21], and 57.5% developed metastatic
brain lesions over the course of their disease [38], a slightly
higher figure than was found in the present study. Given
this high probability of brain involvement in patients with
ISCM, as opposed to only 5% of patients with RCC at
initial presentation [30], imaging studies of the head should
be performed as part of staging.
Half the patients had metastases in the lungs. In fact, the
results of 687 post mortems suggested that RCC follows a
metastatic “cascade” in which the lungs are the first site of
haematogeneous spread [45]. Arterial embolism of pulmo-
nary metastases might seed to other sites but would be an
unlikely means of spread to the spinal cord. Nevertheless,
the absence of pulmonary metastases in our patient suggests
an alternative mechanism of spread via the vertebral venous
plexus, as first proposed by Batson [7] and recently
reviewed by Tobinick and Vega [43]. In addition to
connections with the cranial venous system, the vertebral
venous plexus communicates via widespread anastomoses
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with systemic veins, including the inferior and superior
venae cavae, the left renal and suprarenal veins, and the
azygos and portal venous systems [6, 17]. As blood flow in
the vertebral venous system has been shown to be bi-
directional [7, 17], this venous route provides an accepted
pathway of metastatic seeding [31, 37]. Moreover, angio-
graphic studies have demonstrated retrograde (inward) flow
in the radicular veins and hence a communication between
extra- and intradural compartments of the spine [25]. We
suggest this route as the probable mechanism in our patient,
whose metastasis was located close to the dorsal root. An
alternative pathway is seeding via the cerebrospinal fluid
(CSF), which, given the co-existent brain metastasis, would
also have been possible in our patient. However, the CSF
route seems less likely in patients with no prior or
concomitant brain involvement. Finally, dissemination
along the subarachnoid space via lymph vessels of
peripheral nerves can lead to leptomeningeal invasion
[46]. On the other hand, vertebral bone metastases can
directly invade and/or seed to the CSF [28].
Conclusion
Surgery for ISCM from RCC leads to favourable functional
results and may, in combination with aggressive therapy of
systemic disease progression, prolong survival. Considering
the high risk of brain involvement, imaging of the brain is
mandatory in the staging of patients with ISCM. The
prognosis for patients with ISCM of RCC is as poor as that
of patients with ISCM of other primary tumours. Mortality
is mainly due to the systemic disease.
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Comment
The article by Dr. Jost and colleagues focuses on intradural spinal
metastasis of renal cell cancer. Although intraspinal spread of
neoplasms has been repeatedly reported, the occurrence of metastasis
in the intradural compartment of the spine caused by renal carcinoma
is highly uncommon. The novel and interesting aspects of the present
work particularly lie in the detailed current literature review including
both cases of metastasis to haemangioblastomas in von Hippel-Lindau
disease and sporadic cases of renal cell carcinoma metastasis, and the
conclusion that, although optimal treatment after diagnosis of intra-
dural spinal metastatic disease in renal cell carcinoma remains
controversial, selected patients may have substantially increased
survival and acceptable clinical outcome after surgical resection and
adequate multidisciplinary management. This clearly written and well
arranged review and case presentation of a rare condition is a valuable
contribution to our literature on spinal cord metastasis from systemic
cancer.
Markus Florian Oertel
Germany
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